摘要
目的 探讨社区医院在治疗糖尿病患者时联合以二甲双胍与西格列汀施治的价值。方法 试验对象选于2020.06-2021.07期间，在我院就医的糖尿病患者94例，以随机盲选法均分为对照组与观察组，在治疗期间分别以二甲双胍与联合西格列汀施治，统计施治总有效率及血糖指标。结果 观察组施治总有效率比对照组高P＜0.05，（χ2=6.114）；观察组施治后FPG、2hPG及HbAlc指标低于对照组，P＜0.05（t1=3.550，t2=3.391，t3=3.668）。结论 通过以二甲双胍与西格列汀联合施治，既能够有效增强临床治疗效果，同时还能有效调节患者机体血糖水平，控制在正常范围内，对改善患者生活质量起着积极意义，适宜临床深入研究与推广应用。
关键词： 糖尿病；西格列汀；二甲双胍；施治有效率；血糖水平
Abstract
Objective To explore the value of metformin combined with sitagliptin in the treatment of diabetes patients in community hospitals. Methods the subjects were 94 patients with diabetes who were hospitalized in our hospital from June 2020 to July 2021. They were randomly and blindly divided into control group and observation group. During the treatment period, they were treated with metformin and cigliptin respectively. The total effective rate and blood glucose index were counted. Results the total effective rate of the observation group was higher than that of the control group (P<0.05) (χ2=6.114); The indexes of FPG, 2hPG and HbAlc in the observation group were lower than those in the control group (P<0.05) (t1=3.550，t2=3.391，t3=3.668). Conclusion the combination of metformin and sitagliptin can not only effectively enhance the clinical treatment effect, but also effectively regulate the blood glucose level of patients and control it within the normal range. It plays a positive role in improving the quality of life of patients and is suitable for in-depth clinical research and popularization.
Key words： Diabetes; Sitagliptin; Metformin; Effective treatment; Blood glucose level
参考文献 References
[1]张先玉. 西格列汀联合二甲双胍治疗2型糖尿病的临床效果分析[J]. 糖尿病新世界,2021,24(20):90-93.
[2]朱琳. 西格列汀联合二甲双胍治疗2型糖尿病的疗效及对胰岛功能的影响[J]. 沈阳药科大学学报,2021,38(S1):40.
[3]李晶慧,陈频. 西格列汀联合二甲双胍治疗老年人2型糖尿病临床观察[J]. 深圳中西医结合杂志,2021,31(17):153-155.
[4]姚力莉. 西格列汀联合二甲双胍治疗2型糖尿病的临床效果观察[J]. 中国冶金工业医学杂志,2021,38(04):432.
[5]崔志. 磷酸西格列汀与二甲双胍联用治疗2型糖尿病患者的疗效[J]. 中国实用医药,2021,16(30):127-129.
[6]张先玉. 西格列汀联合二甲双胍治疗2型糖尿病的临床效果分析[J]. 糖尿病新世界,2021,24(20):90-93.
[7]郭红伟,张春. 西格列汀与二甲双胍联合膳食纤维方案治疗糖尿病肥胖的效果观察[J]. 当代医学,2021,27(28):63-65.
[8]王慧, 邝建, 罗涌, et al. 西格列汀对初治2型糖尿病患者胰岛素敏感性及胰岛α和β细胞功能的影响[J]. 中华糖尿病杂志, 2020, 12(6):5.
[9]刘慧莹, 程刚. 西格列汀,格列美脲分别联合二甲双胍治疗2型糖尿病有效性与安全性Meta分析[J]. 临床军医杂志, 2020, 48(2):4.
[10]王锋, 陈亚新, 巫大伟,等. 西格列汀联合二甲双胍治疗肥胖型糖尿病患者的临床研究[J]. 中国临床药理学杂志, 2021, 37(15):4.
[11]员婷. 磷酸西格列汀联合二甲双胍对2型糖尿病患者血糖控制及胰岛素抵抗的治疗效果[J]. 中国医药导报, 2021, 18(6):4.
[12]冯佳, 齐婷, 王述进,等. 加味六黄汤联合西格列汀对初诊2型糖尿病病人血清炎性因子及氧化应激产物的影响[J]. 中西医结合心脑血管病杂志, 2020, 18(15):4.
[13]丰磊, 张婷, 张金金,等. 西格列汀对高糖诱导内皮细胞凋亡的改善作用及机制研究[J]. 安徽医药, 2020, 24(8):4.
[14]杜蓥漩, 王慧. 西格列汀对糖尿病合并高血压患者血压,动脉僵硬度和内皮功能的影响[J]. 广西医学, 2020, 42(10):5.
[15]王莉, 白玲, 岳怀献,等. 西格列汀与维格列汀联合二甲双胍治疗2型糖尿病的有效性及经济性研究[J]. 中国医药, 2021.